Skorpios Trust 13D and 13G filings for Stoke Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-26 5:42 pm Sale | 2025-08-22 | 13D | Stoke Therapeutics, Inc. STOK | Skorpios Trust | 2,256,181 4.100% | -1,000,000 (-30.71%) | Filing |
| 2025-06-23 4:47 pm Sale | 2025-06-18 | 13D | Stoke Therapeutics, Inc. STOK | Skorpios Trust | 3,256,181 6.000% | -650,000 (-16.64%) | Filing |
| 2025-06-06 4:23 pm Sale | 2025-06-04 | 13D | Stoke Therapeutics, Inc. STOK | Skorpios Trust | 3,906,181 7.200% | -3,000,000 (-43.44%) | Filing |
| 2024-12-27 5:23 pm Sale | 2024-12-23 | 13D | Stoke Therapeutics, Inc. STOK | Skorpios Trust | 6,906,181 13.000% | -2,000,000 (-22.46%) | Filing |
| 2024-09-23 4:22 pm Sale | 2024-09-19 | 13D | Stoke Therapeutics, Inc. STOK | Skorpios Trust | 8,906,181 16.900% | -1,937,500 (-17.87%) | Filing |
| 2024-04-18 4:18 pm Sale | 2024-04-17 | 13D | Stoke Therapeutics, Inc. STOK | Skorpios Trust | 10,843,681 23.400% | -3,600,000 (-24.92%) | Filing |
| 2021-06-30 4:19 pm Purchase | 2021-06-21 | 13D | Stoke Therapeutics, Inc. STOK | Skorpios Trust | 14,443,681 39.300% | 14,443,681 (New Position) | Filing |